This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of other and ill-defined digestive organs
C3_DIGESTIVE_ORGANS_NAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
353 |
4. Check minimum number of eventsNone |
353 |
5. Include endpointsNone |
353 |
6. Filter based on genotype QC (FinnGen only) |
305 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and ill-defined digestive organs
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and ill-defined digestive organs, including Hilmo
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 305 | 138 | 167 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.08 |
| Median age at first event (years) | 75.07 | 75.61 | 74.62 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 324
- Matched controls
- 3237
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z51.5
ICD-10 Finland
Palliative care
25.6
166.3
136
89
130
Kela drug reimbursment
Malignant tumour
+∞
156.2
137
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
146.2
129
*
H02AB02
ATC
dexamethasone; systemic
67.1
144.5
81
16
8140/3-C26.9
ICD-O-3
Adenocarcinoma, NOS, of gastrointestinal tract, NOS
+∞
119.3
107
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
81.8
75
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.7
77.8
133
240
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
52.0
77.0
45
10
JN4BD
NOMESCO Finland
Extensive body CT
13.9
74.9
77
71
JN4AD
NOMESCO Finland
Body CT examination
11.9
74.6
87
97
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
65.9
61
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
64.8
60
*
N02AA05
ATC
oxycodone; systemic
6.7
62.4
146
354
A04AA02
ATC
granisetron; systemic, transdermal
714.3
61.9
59
*
8000/3-C26.9
ICD-O-3
Neoplasm, malignant of gastrointestinal tract, NOS
+∞
61.4
57
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
59.2
55
*
A04AA01
ATC
ondansetron; systemic, rectal
18.0
56.5
48
31
R18
ICD-10 Finland
Ascites
25.2
55.2
40
18
L01BC06
ATC
capecitabine; oral
+∞
50.3
47
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
50.3
47
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
39.4
37
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.5
36.7
40
39
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.1
30.7
32
29
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
28.5
27
*
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
+∞
28.5
27
*
JAH00
NOMESCO Finland
Laparotomy
11.7
28.1
30
28
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
27.5
26
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
30.9
27.3
36
13
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
293.9
27.1
27
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.5
27.0
41
61
WZC00
NOMESCO Finland
Treatment plan or consultation
3.6
26.9
126
481
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
26.4
25
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
23.7
68
182
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
35.2
22.8
29
9
WZC30
NOMESCO Finland
Teaching
4.1
21.7
70
204
116
Kela drug reimbursment
Prostate cancer
+∞
21.1
20
*
8936/3-C26.9
ICD-O-3
Gastrointestinal stromal tumor of gastrointestinal tract, NOS
+∞
20.0
19
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
20.0
19
*
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
20.0
19
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
18.9
18
*
8010/3-C26.9
ICD-O-3
Carcinoma, NOS, of gastrointestinal tract, NOS
+∞
18.9
18
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
74.4
18.9
21
*
JAH01
NOMESCO Finland
Laparoscopy
8.0
18.5
26
35
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
24.5
18.0
25
11
8140/3-C26.0
ICD-O-3
Adenocarcinoma, NOS, of intestinal tract, NOS
+∞
17.9
17
*
8000/3-C26.0
ICD-O-3
Neoplasm, malignant of intestinal tract, NOS
+∞
17.9
17
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
17.9
17
*
B01AB10
ATC
tinzaparin; parenteral
4.3
17.7
50
131
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
7.6
17.2
25
35
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
16.8
16
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
16.8
16
*
WF002
NOMESCO Finland
Radical radiotherapy
83.9
14.7
16
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.7
14
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
14.7
14
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
14.7
14
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
78.5
13.7
15
*
L02AE02
ATC
leuprorelin; implant, parenteral
78.5
13.7
15
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
35.7
13.6
17
5
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
13.6
13
*
L03AA13
ATC
pegfilgrastim; parenteral
145.7
13.5
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
13.3
56
192
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
13.1
121
628
189
Kela drug reimbursment
Imatinib
+∞
12.6
12
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
12.6
12
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
12.6
12
*
UJF32
NOMESCO Finland
Coloscopy
2.5
12.5
101
492
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.7
12.2
23
23
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
11.6
90
428
A79
ICPC
Malignancy NOS
+∞
11.5
11
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
L03AA02
ATC
filgrastim; parenteral
124.1
11.5
12
*
ZX120
NOMESCO Finland
Intravenous
3.9
11.4
35
97
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
11.0
45
151
JFB00
NOMESCO Finland
Partial resection of small intestine
29.1
10.8
14
5
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
10.5
10
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
10.5
10
*
Y77
ICPC
Malignant neoplasm prostate
+∞
10.5
10
*
L01XE01
ATC
[U] imatinib
+∞
10.5
10
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
10.5
10
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
10.5
10
*
JEA00
NOMESCO Finland
Appendectomy
5.2
10.4
22
45
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
10.3
118
662
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
10.1
28
72
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.9
9.9
22
47
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
56.7
9.7
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
9.4
9
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
9.4
9
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
9.4
9
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
9.4
9
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
9.4
9
*
8480/3-C26.9
ICD-O-3
Mucinous adenocarcinoma of gastrointestinal tract, NOS
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.8
9.1
11
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
37.8
9.1
11
*
B01AB05
ATC
enoxaparin; parenteral
2.1
9.0
109
619
HAB40
NOMESCO Finland
Wedge excision of mammary gland
51.4
8.7
10
*
JN4CD
NOMESCO Finland
Very extensive body CT
10.4
8.6
16
16
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
8.5
34
112
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
8.5
57
250
H01CB03
ATC
lanreotide; parenteral
92.3
8.4
9
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
8.4
8
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
176
Kela drug reimbursment
Regorafenib
+∞
8.4
8
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.1
8.3
23
59
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.5
8.2
17
21
K83.1
ICD-10 Finland
Obstruction of bile duct
12.1
8.1
14
12
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
34.2
8.1
10
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
10.4
8.1
15
15
SPAT1255
SPAT
Intravenous administration of medicine
3.2
8.0
33
111
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.1
7.8
34
118
ZX090
NOMESCO Finland
Other technic of radiotherapy
46.1
7.7
9
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.0
7.7
35
125
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.2
7.6
15
17
A06AH03
ATC
naloxegol; oral
25.7
7.6
10
*
J94.8
ICD-10 Finland
Other specified pleural conditions
7.9
7.5
16
21
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
81.8
7.4
8
*
WPA44, ,
SPAT
+∞
7.3
7
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
7.3
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
7.3
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.3
7
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
7.3
7
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
7.3
7
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.3
7
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
30.7
7.2
9
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
40.9
6.8
8
*
L02BG04
ATC
letrozole; oral
40.9
6.8
8
*
WW200, ,
SPAT
0.4
6.6
28
670
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.6
6.5
22
65
JFF10
NOMESCO Finland
Loop enterostomy
71.1
6.4
7
*
H01CB02
ATC
octreotide; parenteral
71.1
6.4
7
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.2
6.4
17
42
WW500
NOMESCO Finland
Blood transfusion
5.7
6.4
17
31
OAB44, ,
SPAT
0.1
6.3
*
183
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
6.3
6
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
6.3
6
*
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
6.3
6
*
8240/3-C26.9
ICD-O-3
Neuroendocrine tumor, NOS, of gastrointestinal tract, NOS
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
L01EA01
ATC
imatinib; oral
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
C49.4
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of abdomen
+∞
6.3
6
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
10.3
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
195
141
33.19
233.47
3.6
1.4
199.08
2.89
ug/l
2.63
175
112
112
49
34.37
161.74
3.3
1.9
5161.11
17.03
u/ml
2.00
101
38
44
20
25.28
60.62
1.3
1.8
118.43
187.77
u/ml
0.14
44
20
246
1259
4.95
36.82
12.6
3.7
15.65
12.28
umol/l
1.25
239
1185
38
10
42.74
31.00
4.1
1.6
7.97
5.18
nmol/l
—
38
10
171
794
3.44
26.66
3.0
2.3
47.46
63.63
u/l
1.87
161
732
209
1149
3.30
23.66
7.9
3.8
30.51
34.91
g/l
15.74
201
1073
222
1284
3.31
22.66
15.2
5.4
5.39
4.42
e9/l
3.49
194
1099
218
1350
2.87
17.80
11.9
17.3
1.28
1.36
inr
1.11
182
1132
21
6
37.23
16.87
5.2
1.0
141.71
92.83
nmol/l
—
21
6
64
209
3.57
16.60
2.0
1.9
0.18
0.20
g/l
1.57
58
187
23
32
7.65
15.86
1.3
1.5
3610.38
2105.41
e6/l
0.25
13
22
71
257
3.25
15.59
3.3
2.0
17.67
7.59
umol/l
1.59
71
225
14
0
+∞
14.69
5.6
0.0
62.22
—
u/ml
—
14
0
174
1047
2.43
13.73
3.0
2.4
—
—
estimate
—
0
0
113
565
2.53
13.33
2.5
2.0
—
—
—
0
0
16
5
33.50
12.68
1.4
1.0
2205.80
395.40
e6/l
—
10
5
255
1868
2.71
12.49
15.6
5.4
139.24
79.02
u/l
8.80
244
1728
37
992
0.29
12.27
1.7
2.0
1.32
1.28
mmol/l
0.06
29
806
22
24
9.74
11.18
1.3
1.5
45757.27
2340.31
e6/l
0.86
11
13
198
1356
2.18
10.36
6.7
6.2
1.20
1.21
mmol/l
0.54
168
1160
181
1212
2.11
9.86
6.2
5.5
1.20
1.21
mmol/l
1.38
174
1086
21
50
4.42
8.31
1.5
1.5
—
—
—
0
0
21
53
4.16
7.73
1.4
1.3
—
—
—
0
0
210
1575
1.94
7.39
5.1
4.4
6.96
6.90
mmol/l
0.16
199
1499
75
421
2.01
6.11
2.7
1.7
29.47
29.42
s
0.03
75
404
80
474
1.91
5.54
2.2
2.5
10.98
12.44
umol/l
0.97
70
440
5
0
+∞
5.22
2.0
0.0
48.76
—
pmol/l
—
5
0
211
1678
1.73
5.19
4.9
4.9
1240.29
2056.44
e6/l
—
7
34
74
436
1.90
5.18
2.1
2.5
2.14
2.25
g/l
0.95
67
403
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
94
2.80
5.03
3.1
2.4
0.40
0.41
iu/ml
0.07
18
55
83
514
1.82
4.96
1.9
1.8
—
—
—
0
0
203
2398
0.59
4.87
4.1
6.4
2.63
2.53
mmol/l
0.74
172
2187
9
10
9.21
4.81
1.4
1.5
—
—
—
0
0
112
763
1.71
4.80
4.5
2.6
48.86
35.92
u/l
1.33
107
720
198
2339
0.60
4.50
3.8
5.5
4.51
4.42
mmol/l
0.50
171
2145
16
51
3.25
4.26
3.6
2.2
97.00
87.86
%
0.73
16
51
67
406
1.82
4.25
2.3
2.4
20.77
22.41
%
0.28
59
377
198
2317
0.62
3.98
3.7
5.4
1.40
1.45
mmol/l
0.74
171
2099
199
2321
0.63
3.87
5.9
7.5
41.18
40.77
mmol/mol
0.25
176
2148
105
739
1.62
3.83
3.4
3.1
2.59
0.53
e6/l
0.89
78
548
206
2376
0.63
3.68
4.0
5.6
6.17
6.14
mmol/l
0.11
171
2134
11
26
4.34
3.53
1.4
1.2
—
—
—
0
0
71
1019
0.61
3.33
3.8
4.1
25.08
7.05
mg/mmol
0.69
45
661
190
2209
0.66
3.25
3.4
4.7
1.35
1.26
mmol/l
1.07
162
1976
11
29
3.88
3.21
1.3
1.4
—
—
—
0
0
52
321
1.74
3.08
3.3
3.0
1.93
2.07
mmol/l
0.08
45
277
29
149
2.04
3.00
1.4
1.5
—
—
—
0
0
123
943
1.49
2.93
3.7
3.2
—
—
—
0
0
21
97
2.24
2.83
2.8
3.5
—
—
—
0
0
61
416
1.57
2.46
2.9
3.1
2.45
2.38
e6/l
0.03
25
194
100
759
1.46
2.44
2.4
2.3
3.00
2.97
mg/l
0.05
84
645
55
377
1.55
2.17
1.8
1.8
—
—
—
0
0
53
365
1.54
2.05
5.2
6.1
5.05
5.11
kpa
0.23
53
349
53
365
1.54
2.05
5.2
6.1
11.94
11.18
kpa
0.55
53
349
52
358
1.54
2.02
4.8
6.2
1.56
1.15
mmol/l
0.34
45
291
33
204
1.69
1.98
1.6
1.5
—
—
—
0
0
23
387
0.56
1.93
1.1
1.3
1.62
10.57
u/ml
—
6
129
13
58
2.29
1.93
1.5
1.3
—
—
—
0
0
13
58
2.29
1.93
1.5
1.3
—
—
—
0
0
27
160
1.75
1.88
2.7
4.3
2.48
2.28
mmol/l
0.09
20
114
30
189
1.65
1.69
2.7
4.3
5.11
5.14
kpa
0.06
30
181
83
648
1.38
1.68
3.3
2.5
342.21
363.99
umol/l
0.99
68
558
14
69
2.07
1.67
1.2
1.2
141.00
330.87
ug/g
—
6
43
27
418
0.61
1.66
1.1
1.3
35.02
37.35
iu/ml
—
5
129
76
587
1.38
1.64
1.9
1.8
1101.64
1200.40
nmol/l
0.29
60
451
27
167
1.67
1.64
8.3
8.1
15.79
15.63
%
0.10
27
161
19
106
1.84
1.62
2.3
1.7
—
—
—
0
0
5
14
3.61
1.62
1.2
1.0
—
—
—
0
0
32
209
1.59
1.58
4.3
5.3
24.97
24.59
mmol/l
0.19
32
199
18
100
1.85
1.56
2.2
1.6
—
—
—
0
0
60
449
1.41
1.55
2.9
2.9
2.04
1.33
e6/l
0.30
24
228
35
502
0.66
1.53
1.3
1.3
0.73
1.50
u/ml
—
10
134
54
398
1.43
1.52
1.9
1.8
—
—
—
0
0
258
2394
1.38
1.52
28.9
16.1
47.68
25.85
mg/l
11.07
250
1957
166
1458
1.28
1.42
3.9
3.0
118.35
52.20
u/l
3.97
157
1352
207
2252
0.77
1.39
3.9
5.2
1.97
1.98
mu/l
0.04
183
2033
15
257
0.56
1.37
1.2
1.4
—
—
—
0
0
0
38
0.00
1.35
0.0
1.7
—
—
—
0
0
5
19
2.65
1.22
1.6
1.5
82.00
80.68
umol/l
—
5
19
38
276
1.43
1.18
4.1
3.3
—
—
—
0
0
135
1181
1.24
1.13
3.4
4.3
31.80
71.69
ng/l
0.86
107
918
16
96
1.70
1.12
1.1
1.3
—
—
—
0
0
5
21
2.40
1.09
1.0
1.0
—
—
—
0
0
102
1180
0.80
1.07
2.3
2.6
—
—
—
0
0
10
53
1.91
1.02
1.0
1.6
—
—
—
0
0
13
77
1.72
0.96
1.1
1.2
1.41
1.53
ratio
—
6
50
24
335
0.69
0.94
2.7
5.5
29.60
32.60
%
—
10
208
171
1855
0.83
0.88
3.3
4.0
15.18
15.14
pmol/l
0.06
148
1666
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
24
171
1.43
0.85
7.2
8.2
24.04
24.49
mmol/l
0.27
24
165
26
189
1.41
0.83
1.8
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
17
115
1.50
0.78
1.6
2.7
2.01
1.44
mmol/l
0.63
17
109
65
546
1.24
0.77
2.0
1.7
3.77
1.30
mg/l
2.65
59
436
7
38
1.86
0.74
1.4
1.1
—
—
—
0
0
5
26
1.94
0.71
1.8
1.0
—
—
—
0
0
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
23
174
1.35
0.61
1.4
2.5
1.89
1.16
%
1.38
23
174
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
10
65
1.55
0.56
1.8
1.2
—
—
—
0
0
81
903
0.86
0.53
1.7
1.8
19.93
20.06
nmol/l
0.03
68
757
22
170
1.31
0.53
1.4
2.4
0.89
0.60
%
1.22
22
170
68
598
1.17
0.52
3.6
4.6
97.62
227.18
ng/l
0.84
63
512
48
558
0.83
0.52
3.5
2.9
0.78
0.84
ug/l
0.26
32
384
6
40
1.51
0.52
3.0
3.5
7.42
12.59
pmol/l
—
6
40
9
65
1.39
0.51
1.8
1.2
—
—
—
0
0
12
84
1.44
0.50
1.3
1.3
0.00
0.00
g/l
-0.00
12
77
7
46
1.53
0.48
1.1
1.2
—
16.84
—
0
5
218
2267
0.88
0.48
30.8
15.8
74.63
72.33
ml/min/173m2
0.75
211
2107
105
1141
0.88
0.47
2.2
2.5
71.01
80.51
nmol/l
2.32
87
1002
28
228
1.25
0.47
3.0
3.6
74.66
93.18
ng/l
0.97
23
197
13
94
1.40
0.46
1.3
1.3
0.72
0.45
g/l
0.20
13
84
123
1315
0.89
0.42
2.0
2.3
94.73
94.80
pmol/l
0.00
70
674
0
15
0.00
0.41
0.0
3.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
15
114
1.33
0.41
1.3
1.3
4.17
4.23
g/l
0.07
15
102
15
114
1.33
0.41
1.3
1.3
4.39
3.70
g/l
0.65
15
102
15
114
1.33
0.41
1.3
1.3
8.51
7.70
g/l
1.04
15
102
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
20
159
1.27
0.41
2.1
2.9
25.82
25.20
mmol/l
0.36
20
150
57
639
0.87
0.41
3.5
4.5
1.02
1.02
kg/l
0.77
43
422
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
179.76
—
0
18
14
106
1.33
0.39
1.3
1.3
3.64
3.07
g/l
0.93
14
94
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.7
—
85.48
—
0
19
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
256
2487
1.14
0.39
19.2
10.3
30.44
24.58
u/l
2.20
247
2387
9
66
1.37
0.38
1.1
1.2
—
—
—
0
0
257
2498
1.13
0.38
31.6
20.8
137.89
139.71
mmol/l
15.91
251
2437
6
41
1.47
0.36
6.0
2.5
10.22
11.02
mmol/l
—
6
41
257
2501
1.13
0.36
31.9
20.9
4.00
4.01
mmol/l
0.41
251
2436
16
199
0.79
0.34
1.4
1.5
—
—
—
0
0
7
100
0.69
0.31
1.7
1.3
—
—
—
0
0
7
53
1.33
0.31
1.1
2.6
1.17
1.19
mmol/l
—
7
53
74
800
0.90
0.30
4.6
4.1
20.78
24.91
%
1.39
42
411
11
84
1.32
0.30
1.4
1.3
0.00
0.00
g/l
-0.00
11
73
7
55
1.28
0.30
1.1
2.5
102.43
105.33
mmol/l
—
7
55
17
205
0.82
0.29
1.2
1.4
—
—
—
0
0
24
205
1.18
0.28
1.8
2.7
121.83
129.68
g/l
1.05
24
197
193
1864
1.09
0.28
3.9
4.3
24.40
13.29
mm/h
7.41
177
1700
20
236
0.84
0.28
4.0
2.5
0.86
0.40
e6/l
0.39
20
217
5
71
0.70
0.26
1.2
1.2
—
—
—
0
0
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
273.83
—
0
6
0
11
0.00
0.21
0.0
1.8
—
184.73
—
0
11
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
4.63
—
0
8
258
2534
1.08
0.21
36.0
22.0
83.31
84.08
umol/l
0.13
252
2490
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1.08
—
0
9
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
31
341
0.90
0.18
9.5
7.4
—
—
—
0
0
102
1063
0.94
0.18
2.8
3.4
1656.64
1757.68
ng/l
0.11
90
917
109
1133
0.94
0.18
2.9
2.9
308.67
127.82
ug/l
0.65
96
1029
61
646
0.93
0.17
1.8
1.9
485.93
436.06
pmol/l
0.27
47
530
20
177
1.14
0.16
2.5
3.7
47.86
48.85
%
0.06
20
172
98
1019
0.94
0.16
4.1
4.4
0.00
0.01
estimate
0.74
34
210
74
704
1.07
0.15
4.6
3.9
0.00
0.00
estimate
-0.00
34
209
8
97
0.82
0.14
1.0
1.0
—
—
—
0
0
80
768
1.05
0.13
4.1
4.1
0.00
0.00
estimate
-0.00
31
248
192
1885
1.04
0.12
35.6
19.8
14.90
13.78
%
11.34
192
1856
18
198
0.90
0.11
4.3
2.2
60.29
56.14
ml/min/173m2
—
7
81
5
61
0.82
0.08
2.4
1.1
—
—
—
0
0
5
64
0.78
0.08
1.4
1.8
—
—
—
0
0
31
294
1.06
0.07
2.0
2.7
2.71
7.10
ug/l
3.02
22
257
133
1350
0.97
0.06
3.8
4.3
0.00
0.03
estimate
0.79
35
264
130
1319
0.97
0.06
3.8
4.3
0.00
0.00
estimate
-0.00
37
272
132
1339
0.97
0.06
3.8
4.3
0.00
0.00
estimate
-0.00
37
280
258
2560
1.03
0.06
39.2
24.1
91.17
91.65
fl
0.64
252
2518
258
2561
1.03
0.05
39.7
24.5
36.85
39.84
%
17.82
252
2518
258
2561
1.03
0.05
39.3
24.1
274.80
239.55
e9/l
6.79
249
2495
258
2561
1.03
0.05
39.3
24.1
4.11
4.43
e12/l
18.04
250
2481
99
1007
0.97
0.05
4.5
4.4
2.76
2.17
ug/l
0.85
87
887
12
118
1.02
0.00
2.0
2.1
479.92
686.82
ug/l
0.19
12
111
25
249
1.00
0.00
2.8
1.7
399.32
386.47
nmol/l
0.08
25
224
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
74
0.94
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.4
—
791.41
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
1734.33
—
0
6
7
74
0.94
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
9.44
—
0
7
5
50
1.00
-0.00
1.0
1.2
24.94
16.72
u/l
—
5
45
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
1.20
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_DIGESTIVE_ORGANS_NAS – Malignant neoplasm of other and ill-defined digestive organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).